查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
肿瘤消融市场规模、份额和成长分析（按消融类型、手术类型、应用、最终用户和地区划分）－2026-2033年产业预测
市场调查报告书
商品编码
1899662

肿瘤消融市场规模、份额和成长分析（按消融类型、手术类型、应用、最终用户和地区划分）－2026-2033年产业预测

Oncology Ablation Market Size, Share, and Growth Analysis, By Type of Ablation (Radiofrequency Ablation (RFA), Microwave Ablation (MWA)), By Procedure Type, By Application, By End User, By Region - Industry Forecast 2026-2033
出版日期: | 出版商: SkyQuest | 英文 225 Pages | 商品交期: 3-5个工作天内

价格
简介目录

全球肿瘤消融市场规模预计在 2024 年达到 15 亿美元，从 2025 年的 17 亿美元成长到 2033 年的 47.2 亿美元，在预测期（2026-2033 年）内复合年增长率为 13.6%。

全球癌症消融市场正经历强劲成长，这主要得益于癌症发生率的显着上升，尤其是在低收入国家，同时，人们对更安全治疗方法的需求也在不断增长。预计高所得地区的癌症发生率将成长41%，而新兴市场的新增癌症病例数可能成长超过80%。这一增长得益于多种治疗方法的出现以及人们对微创和非侵入性治疗的偏好。外科医生和患者越来越多地选择先进的肿瘤消融技术，认为其具有恢復更快、患者舒适度更高等优势，并逐渐抛弃传统治疗方法。此外，与先进肿瘤消融技术相关的门诊手术不仅成为治疗小型肿瘤的首选方案，而且透过将年度癌症筛检率与手术数量挂钩，还有助于降低整体医疗保健成本。

全球肿瘤消融市场驱动因素

全球肿瘤消融市场预计将在先进肿瘤消融技术需求不断增长的推动下实现显着增长。外科医师和患者越来越倾向于选择微创手术，因为微创手术具有许多优势，例如恢復速度更快、患者舒适度更高、术后恢復时间更短。这种偏好的转变凸显了肿瘤学领域技术和调查方法的进步，使这些手术更容易获得且更具吸引力。人们对这些优势的认识不断提高，有望促进创新消融技术的应用，扩大这些治疗方法在有效癌症治疗中的应用范围，并增强市场动态。

限制全球肿瘤消融市场发展的因素

全球癌症消融市场面临许多挑战，可能阻碍其成长。随着肿瘤消融疗法被公认为治疗方法多种固态器官癌症的有效方法，手术的复杂性也可能随之增加。常见的併发症包括出血和目标器官损伤，这些都是该疗法常见的不利事件。这些併发症会带来重大风险，并可能使患者和医疗机构对消融疗法望而却步。因此，这些手术的潜在副作用可能会成为阻碍肿瘤治疗领域市场发展的障碍。

全球肿瘤消融市场趋势

在全球癌症消融市场，采用创新技术，特别是冷却射频探头，以提高治疗效果和安全性，已成为显着趋势。市场参与者日益关注能够提升精准度、便携性和成本效益的技术进步，例如高强度聚焦超音波（HIFU）、冷冻消融和先进的影像导引系统等领域的进展。在此背景下，新型冷却射频神经消融技术正成为关键驱动因素，能够对骶髂关节的神经进行全面消融，进而改善疼痛管理。这项技术与患者照护之间的协同作用，反映了改善治疗效果的更广泛趋势，预计将推动肿瘤消融市场的显着成长。

目录

介绍

  • 调查目标
  • 调查范围
  • 定义

调查方法

  • 资讯收集
  • 二手资料和一手资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 细分市场机会分析

市场动态与展望

  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 限制与挑战
  • 波特分析

关键市场考察

  • 关键成功因素
  • 竞争程度
  • 关键投资机会
  • 市场生态系统
  • 市场吸引力指数（2025）
  • PESTEL 分析
  • 总体经济指标
  • 价值链分析
  • 定价分析
  • 技术分析
  • 监管分析
  • 专利分析
  • 案例研究

全球肿瘤消融市场规模（依消融类型及复合年增长率划分）（2026-2033 年）

  • 射频消融术（RFA）
  • 微波消融术（MWA）
  • 雷射消熔
  • 冷冻消融术
  • 不可逆电穿孔（IRE）
  • 高强度聚焦超音波（HIFU）
  • 其他的

全球肿瘤消融市场规模（按手术类型和复合年增长率划分）（2026-2033 年）

  • 微创消融术
  • 外科消融术

全球肿瘤消融市场规模（按应用及复合年增长率划分）（2026-2033 年）

  • 肝癌
  • 肺癌
  • 肾癌
  • 乳癌
  • 摄护腺癌
  • 骨癌
  • 其他的

全球肿瘤消融市场规模（按最终用户和复合年增长率划分）（2026-2033 年）

  • 医院
  • 癌症研究所
  • 专科诊所
  • 门诊手术中心（ASC）

全球肿瘤消融市场规模及复合年增长率（2026-2033）

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 亚太其他地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东和非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东和非洲地区

竞争资讯

  • 前五大公司对比
  • 主要企业的市场定位（2025 年）
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市占率分析（2025 年）
  • 主要企业公司简介
    • 公司详情
    • 产品系列分析
    • 依业务板块进行公司股票分析
    • 2023-2025年营收年比比较

主要企业简介

  • Angiodynamics（Covidien）（US）
  • Boston Scientific Corporation（US）
  • Medtronic Plc（US）
  • Ethicon, Inc.（US）
  • Galil Medical Inc.（US）
  • Misonix Inc.（US）
  • HealthTronics（US）
  • Mermaid Medical（Denmark）
  • Theraclion（France）
  • Chongqing Haifu Medical Technology Co., Ltd.（China）
  • HS Hospital Service SPA（Italy）
  • Hologic, Inc.（US）
  • Varian Medical Systems（US）
  • Cook Medical（US）
  • LeVeen Medical（US）
  • Integra LifeSciences（US）
  • MedWaves, Inc.（US）
  • Sanarus Technologies, Inc.（US）
  • Bovie Medical Corporation（US）
  • ThermoLife（US）

结论与建议

简介目录
Product Code: SQSG35B2038

Global Oncology Ablation Market size was valued at USD 1.5 Billion in 2024 and is poised to grow from USD 1.7 Billion in 2025 to USD 4.72 Billion by 2033, growing at a CAGR of 13.6% during the forecast period (2026-2033).

The global oncology ablation market is witnessing robust growth driven by an increasing demand for safer treatment options alongside a significant rise in cancer incidence, particularly in low-income countries. While high-income regions face a 41% increase, emerging markets may see over 80% growth in new cancer cases. This expansion is fueled by the availability of various therapeutic approaches and a preference for minimally invasive and non-invasive treatments. Surgeons and patients are increasingly favoring advanced tumor ablation techniques due to advantages such as quicker recovery and enhanced patient comfort, leading to a shift from conventional therapies. Furthermore, outpatient procedures associated with advanced tumor ablation options not only serve as the preferred choice for smaller tumors but also reduce overall healthcare costs, linking the procedure volume to annual cancer screening rates.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Oncology Ablation market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Oncology Ablation Market Segments Analysis

Global Oncology Ablation Market is segmented by Type of Ablation, Procedure Type, Application, End User and region. Based on Type of Ablation, the market is segmented into Radiofrequency Ablation (RFA), Microwave Ablation (MWA), Laser Ablation, Cryoablation, Irreversible Electroporation (IRE), High-Intensity Focused Ultrasound (HIFU) and Others. Based on Procedure Type, the market is segmented into Minimally Invasive Ablation and Surgical Ablation. Based on Application, the market is segmented into Liver Cancer, Lung Cancer, Kidney Cancer, Breast Cancer, Prostate Cancer, Bone Cancer and Others. Based on End User, the market is segmented into Hospitals, Cancer Research Institutes, Specialty Clinics and Ambulatory Surgical Centers (ASCs). Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Oncology Ablation Market

The Global Oncology Ablation market is expected to see significant growth driven by the rising demand for advanced tumor ablation techniques. Surgeons and patients are increasingly favoring minimally invasive procedures, which offer numerous benefits such as rapid recovery, enhanced patient comfort, and reduced downtime. This shift in preference highlights the advancements in technology and methodology within the oncology sector, making these procedures more accessible and appealing. As awareness of these benefits spreads, the inclination towards utilizing innovative ablation methods is likely to enhance market dynamics and expand the reach of treatments aimed at effectively managing cancer.

Restraints in the Global Oncology Ablation Market

The Global Oncology Ablation market faces several challenges that may inhibit its growth. As tumor ablation therapy gains traction as a viable treatment method for various solid organ cancers, the complexity of procedures may escalate. Common complications include blood loss and damage to the target organ, which are frequent adverse effects associated with these treatments. Such complications pose significant risks and can discourage patients and healthcare providers from opting for ablation therapies. Consequently, the potential side effects related to these procedures may create obstacles that could hinder overall market advancement and acceptance in the oncology treatment landscape.

Market Trends of the Global Oncology Ablation Market

The global oncology ablation market is witnessing a notable trend towards the adoption of innovative technologies, particularly cooled radiofrequency probes, which are enhancing treatment efficacy and safety. Market players are increasingly focusing on advancements that boost accuracy, portability, and cost-effectiveness, exemplified by developments in high-intensity focused ultrasound (HIFU), cryoablation, and sophisticated image-guided systems. Among these, the novel cooled radiofrequency denervation technique is emerging as a key driver, enabling comprehensive denervation of the sacroiliac joint, thus improving pain management. This synergy of technology and patient care is expected to propel significant growth within the oncology ablation market, reflecting a broader trend towards improved therapeutic outcomes.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2025
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Technology Analysis
  • Regulatory Analysis
  • Patent Analysis
  • Case Studies

Global Oncology Ablation Market Size by Type of Ablation & CAGR (2026-2033)

  • Market Overview
  • Radiofrequency Ablation (RFA)
  • Microwave Ablation (MWA)
  • Laser Ablation
  • Cryoablation
  • Irreversible Electroporation (IRE)
  • High-Intensity Focused Ultrasound (HIFU)
  • Others

Global Oncology Ablation Market Size by Procedure Type & CAGR (2026-2033)

  • Market Overview
  • Minimally Invasive Ablation
  • Surgical Ablation

Global Oncology Ablation Market Size by Application & CAGR (2026-2033)

  • Market Overview
  • Liver Cancer
  • Lung Cancer
  • Kidney Cancer
  • Breast Cancer
  • Prostate Cancer
  • Bone Cancer
  • Others

Global Oncology Ablation Market Size by End User & CAGR (2026-2033)

  • Market Overview
  • Hospitals
  • Cancer Research Institutes
  • Specialty Clinics
  • Ambulatory Surgical Centers (ASCs)

Global Oncology Ablation Market Size & CAGR (2026-2033)

  • North America (Type of Ablation, Procedure Type, Application, End User)
    • US
    • Canada
  • Europe (Type of Ablation, Procedure Type, Application, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Type of Ablation, Procedure Type, Application, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Type of Ablation, Procedure Type, Application, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Type of Ablation, Procedure Type, Application, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2025
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2025
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

  • Angiodynamics (Covidien) (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston Scientific Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic Plc (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ethicon, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Galil Medical Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Misonix Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HealthTronics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mermaid Medical (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Theraclion (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Chongqing Haifu Medical Technology Co., Ltd. (China)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • HS Hospital Service S.P.A (Italy)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hologic, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Varian Medical Systems (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • LeVeen Medical (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Integra LifeSciences (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • MedWaves, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Sanarus Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bovie Medical Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • ThermoLife (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations